TY - JOUR
T1 - Polymyalgia rheumatica. Nieuwe mogelijkheden voor behandeling, maar niet voor diagnostiek.
AU - Lems, Willem F.
AU - Bijlsma, J. W. J. Hans
PY - 2010
Y1 - 2010
N2 - Polymyalgia rheumatica (PMR) is a chronic inflammatory rheumatic disorder, which predominantly occurs in patients aged 50 years and older. It can be difficult to differentiate PMR from other diseases, for general practitioners as well as for rheumatologists. Arteritis temporalis should not be overlooked in these patients, since missing this diagnosis may lead to irreversible visual loss. The majority of patients in whom PMR is suspected respond well to treatment with prednisone 15 mg per day. Methotrexate is an attractive alternative in patients who do not respond to prednisone or who experience side-effects due to prednisone.
AB - Polymyalgia rheumatica (PMR) is a chronic inflammatory rheumatic disorder, which predominantly occurs in patients aged 50 years and older. It can be difficult to differentiate PMR from other diseases, for general practitioners as well as for rheumatologists. Arteritis temporalis should not be overlooked in these patients, since missing this diagnosis may lead to irreversible visual loss. The majority of patients in whom PMR is suspected respond well to treatment with prednisone 15 mg per day. Methotrexate is an attractive alternative in patients who do not respond to prednisone or who experience side-effects due to prednisone.
UR - https://www.scopus.com/pages/publications/77953106301
UR - https://www.ncbi.nlm.nih.gov/pubmed/20482925
M3 - Article
C2 - 20482925
SN - 0028-2162
VL - 154
JO - Nederlands tijdschrift voor geneeskunde
JF - Nederlands tijdschrift voor geneeskunde
M1 - A2048
ER -